65 related articles for article (PubMed ID: 28941328)
1. Inducing indel mutation in the SOX6 gene by zinc finger nuclease for gamma reactivation: An approach towards gene therapy of beta thalassemia.
Modares Sadeghi M; Shariati L; Hejazi Z; Shahbazi M; Tabatabaiefar MA; Khanahmad H
J Cell Biochem; 2018 Mar; 119(3):2512-2519. PubMed ID: 28941328
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia.
Ma SP; Gao XX; Zhou GQ; Zhang HK; Yang JM; Wang WJ; Song XM; Chen HY; Lu DR
Gene; 2022 Apr; 820():146289. PubMed ID: 35143940
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional silencing of fetal hemoglobin expression by NonO.
Li X; Chen M; Liu B; Lu P; Lv X; Zhao X; Cui S; Xu P; Nakamura Y; Kurita R; Chen B; Huang DCS; Liu DP; Liu M; Zhao Q
Nucleic Acids Res; 2021 Sep; 49(17):9711-9723. PubMed ID: 34379783
[TBL] [Abstract][Full Text] [Related]
4. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.
Psatha N; Georgakopoulou A; Li C; Nandakumar V; Georgolopoulos G; Acosta R; Paschoudi K; Nelson J; Chee D; Athanasiadou A; Kouvatsi A; Funnell APW; Lieber A; Yannaki E; Papayannopoulou T
Blood; 2021 Oct; 138(17):1540-1553. PubMed ID: 34086867
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia.
Cai DL; Chan Y; Kong YM; Liu YZ; Guo Y; Cai AQ; Zhu BS
Eur J Pharmacol; 2024 Apr; 968():176404. PubMed ID: 38382804
[TBL] [Abstract][Full Text] [Related]
6. Small molecule therapeutics to treat the β-globinopathies.
Yu L; Myers G; Engel JD
Curr Opin Hematol; 2020 May; 27(3):129-140. PubMed ID: 32167945
[TBL] [Abstract][Full Text] [Related]
7. Machine learning-based approaches for identifying human blood cells harboring CRISPR-mediated fetal chromatin domain ablations.
Li Y; Zaheri S; Nguyen K; Liu L; Hassanipour F; Pace BS; Bleris L
Sci Rep; 2022 Jan; 12(1):1481. PubMed ID: 35087158
[TBL] [Abstract][Full Text] [Related]
8. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia.
Wang H; Georgakopoulou A; Psatha N; Li C; Capsali C; Samal HB; Anagnostopoulos A; Ehrhardt A; Izsvák Z; Papayannopoulou T; Yannaki E; Lieber A
J Clin Invest; 2019 Feb; 129(2):598-615. PubMed ID: 30422819
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy and Gene Editing for β-Thalassemia.
Christakopoulos GE; Telange R; Yen J; Weiss MJ
Hematol Oncol Clin North Am; 2023 Apr; 37(2):433-447. PubMed ID: 36907613
[TBL] [Abstract][Full Text] [Related]
10. α-globin Alteration in α-thalassemia Disorder: Prediction and Interaction Defect.
Handayani NSN; Husna N; Sanka I
Pak J Biol Sci; 2017; 20(7):343-349. PubMed ID: 29023066
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of α-thalassemia.
Farashi S; Harteveld CL
Blood Cells Mol Dis; 2018 May; 70():43-53. PubMed ID: 29032940
[TBL] [Abstract][Full Text] [Related]
12. Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia.
Darbari DS; Vaughan KJ; Roskom K; Seamon C; Diaw L; Quinn M; Conrey A; Schechter AN; Haythornthwaite JA; Waclawiw MA; Wallen GR; Belfer I; Taylor JG
Scand J Pain; 2017 Oct; 17():279-286. PubMed ID: 28969994
[TBL] [Abstract][Full Text] [Related]
13. β-Thalassemia gene editing therapy: Advancements and difficulties.
Hu J; Zhong Y; Xu P; Xin L; Zhu X; Jiang X; Gao W; Yang B; Chen Y
Medicine (Baltimore); 2024 May; 103(18):e38036. PubMed ID: 38701251
[TBL] [Abstract][Full Text] [Related]
14. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.
Paschoudi K; Yannaki E; Psatha N
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298481
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing-Based Technologies for
Rahimmanesh I; Boshtam M; Kouhpayeh S; Khanahmad H; Dabiri A; Ahangarzadeh S; Esmaeili Y; Bidram E; Vaseghi G; Haghjooy Javanmard S; Shariati L; Zarrabi A; Varma RS
Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741383
[TBL] [Abstract][Full Text] [Related]
16. Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through.
Gurumoorthy N; Nordin F; Tye GJ; Wan Kamarul Zaman WS; Ng MH
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052787
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Insights and Potential Modifiers as Therapeutic Targets in
Zakaria NA; Islam MA; Abdullah WZ; Bahar R; Mohamed Yusoff AA; Abdul Wahab R; Shamsuddin S; Johan MF
Biomolecules; 2021 May; 11(5):. PubMed ID: 34070036
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.
de Almeida NAA; Ribeiro CRA; Raposo JV; de Paula VS
Viruses; 2021 May; 13(5):. PubMed ID: 34063186
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of Sox6 in the renal and cardiovascular system.
Saleem M; Barturen-Larrea P; Gomez JA
Physiol Rep; 2020 Nov; 8(22):e14604. PubMed ID: 33230925
[TBL] [Abstract][Full Text] [Related]
20. Nucleic Acid Therapy for β-Thalassemia.
d'Arqom A
Biologics; 2020; 14():95-105. PubMed ID: 32982166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
